Your browser doesn't support javascript.
loading
CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelines.
Drögemöller, Britt I; Wright, Galen E B; Shih, Joanne; Monzon, Jose G; Gelmon, Karen A; Ross, Colin J D; Amstutz, Ursula; Carleton, Bruce C.
Affiliation
  • Drögemöller BI; BC Children's Hospital Research Institute, Vancouver, BC, Canada.
  • Wright GEB; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada.
  • Shih J; BC Children's Hospital Research Institute, Vancouver, BC, Canada.
  • Monzon JG; Department of Medical Genetics, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Gelmon KA; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada.
  • Ross CJD; Tom Baker Cancer Centre, Calgary, AB, Canada.
  • Amstutz U; BC Cancer Agency and University of British Columbia, Vancouver, BC, Canada.
  • Carleton BC; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada.
Breast Cancer Res Treat ; 173(3): 521-532, 2019 Feb.
Article in En | MEDLINE | ID: mdl-30411242

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Genetic Variation / Breast Neoplasms / Receptors, Estrogen / Cytochrome P-450 CYP2D6 Type of study: Diagnostic_studies / Guideline / Prognostic_studies / Systematic_reviews Limits: Female / Humans Language: En Journal: Breast Cancer Res Treat Year: 2019 Type: Article Affiliation country: Canada

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Genetic Variation / Breast Neoplasms / Receptors, Estrogen / Cytochrome P-450 CYP2D6 Type of study: Diagnostic_studies / Guideline / Prognostic_studies / Systematic_reviews Limits: Female / Humans Language: En Journal: Breast Cancer Res Treat Year: 2019 Type: Article Affiliation country: Canada